Generic Drug Market in Canada

Table of Contents

1. Analyst View

2. Canadian Pharmaceutical Market

• 2.1 Market Size & Growth
  • 2.1.1 Prescriptions
  • 2.1.2 Sales
• 2.2 Key Therapy Areas
• 2.3 Branded & Generic Drugs
• 2.4 Sources of Drug Payment
• 2.5 Key Players
  • 2.5.1 Prescriptions
  • 2.5.2 Sales
• 2.6 Top Selling Drugs
  • 2.6.1 Prescriptions
  • 2.6.2 Sales

3. Canadian Generic Market

• 3.1 Market Size & Growth
  • 3.1.1 Prescriptions
  • 3.1.2 Sales
• 3.2 Key Players
  • 3.2.1 Prescriptions
  • 3.2.2 Sales
• 3.3 Market Segmentation
  • 3.3.1 Distribution Channels
    • 3.3.1.1 Retail Pharmacies
      • 3.3.1.1.1 Sales
      • 3.3.1.1.2 Key Players
    • 3.3.1.2 Hospital Pharmacies
      • 3.3.1.2.1 Sales
      • 3.3.1.2.2 Key Players
  • 3.3.2 Authorized & Independent Generics
  • 3.3.3 Province/Territory
    • 3.3.3.1 Drug Consumption
    • 3.3.3.2 Prescriptions
    • 3.3.3.3 Sales
• 3.4 Generic Approval Process
  • 3.4.1 Abbreviated New Drug Submission
  • 3.4.2 Notice of Allegation

4. Industry Analysis

• 4.1 Market Drivers
  • 4.1.1 Huge Cost Savings
  • 4.1.2 Favorable Political Environment
  • 4.1.3 Patent Expirations
  • 4.1.4 Ageing Population
  • 4.1.5 High Returns for Pharmacists
• 4.2 Opportunity Areas
  • 4.2.1 Cardiovascular Drugs
  • 4.2.2 Cancer Drugs
  • 4.2.3 Psychotherapeutics
  • 4.2.4 Antidiabetics
  • 4.2.5 Drug Packaging & Delivery Market
• 4.3 Restraining Factors
  • 4.3.1 Extension of Data Exclusivity
  • 4.3.2 Export Restrictions
  • 4.3.3 Evergreening of Drug Patents
  • 4.3.4 Authorized Generics
• 4.4 Future Outlook (2008-2012)
  • 4.4.1 Driving & Restraining Forces
  • 4.4.2 Future Scenario (2008-2012)

5. Supporting Databases

• 5.1 Macroeconomic Indicators
• 5.2 Population Profile
• 5.3 Age Profile
• 5.4 Healthcare Spending & Infrastructure

6. Key Player Profiles

• 6.1 Apotex Inc
• 6.2 Mylan Laboratories Inc
• 6.3 Teva Pharmaceutical Industries Limited
• 6.4 Ratiopharm GmbH
• 6.5 Sandoz Inc
• 6.6 Pharmascience Inc.

List of Figures:

• Figure 2-1: Canada - Prescriptions Dispensed* in Pharmaceutical Market (in ‘000), 2001-2007E
• Figure 2-2: Canada - Pharmaceutical Sales* (in Billion CA$), 2001-2007E
• Figure 2-3: Canada - Pharmaceutical Purchases* by Retail & Hospital Pharmacies (in Billion CA$), 2001-2007E
• Figure 2-4: Canada - Deaths by Various Causes (%), 2005-2007E
• Figure 2-5: Canada - Share of Generic & Branded Drug by Prescription* (%), 2007E
• Figure 2-6: Canada - Share of Generic & Branded Drug by Sales (%), 2007E
• Figure 2-7: Canada - Drug Financing by Source (%), 2006
• Figure 3-1: Canada - Prescriptions Dispensed* in Branded Drug Market (in ‘000), 2001-2007E
• Figure 3-2: Canada - Prescriptions Dispensed* in Generic Drug Market (in ‘000), 2001-2007E
• Figure 3-3: Canada - Share of Generic & Branded Drug by Prescription (%), 2001-2007E
• Figure 3-4: Canada - Generic Drug Sales (in Billion CA$), 2001-2007E
• Figure 3-5: Canada - Branded Drug Sales (in Billion CA$), 2001-2007E
• Figure 3-6: Canada - Share of Generic & Branded Drug by Sales (%), 2001-2007E
• Figure 3-7: Canada - Relation between Brand Sales & Number of Generic Entrants
• Figure 3-8: Canada - Branded Drug Sales through Retail Pharmacies (in Billion CA$), 2004-2007E
• Figure 3-9: Canada - Generic Drug Sales through Retail Pharmacies (in Billion CA$), 2004-2007E
• Figure 3-10: Canada - Share of Generic & Branded Drug Sales through Retail Pharmacies (%), 2004-2007E
• Figure 3-11: Canada - Branded Drug Sales through Hospital Pharmacies (in Billion CA$), 2004-2007E
• Figure 3-12: Canada - Generic Drug Sales through Hospital Pharmacies (in Billion CA$), 2004-2007E
• Figure 3-13: Canada - Share of Generic & Branded Drug Sales through Hospital Pharmacies (%), 2004-2007E
• Figure 3-14: Canada - Share of Independent Generic & Authorized Generic Prescriptions (%), 2001-2007E
• Figure 4-1: Canada - Average Cost of Branded & Generic Drug (in CA$), 2001-2006
• Figure 4-2: Canada - Population above 65 Years of Age (in Million), 2001-2007E
• Figure 4-3: Canada - Relative Per Capita Spending on Drug by Age Group
• Figure 4-4: Canada - Cardiovascular Drug Market* (in Billion CA$), 2005-2007E & 2012F
• Figure 4-5: Canada - Antineoplastics Market* (in Million CA$), 2005**, 2006** & 2012F**
• Figure 4-6: Canada - Psychotherapeutics Market* (in Billion CA$), 2005-2007E & 2012F
• Figure 4-7: Canada - Number of Diabetes Patients in Age Group 20-79 Years (in ‘000), 2003, 2007E & 2025F
• Figure 4-8: Canada - Diabetes Market* (in Million CA$), 2005-2007E & 2012F
• Figure 4-9: Canada - Forecast for Population above 65 Years of Age (in Million), 2008-2011
• Figure 4-10: Canada - Forecast for Deaths by Various Causes (%), 2008-2012 & 2030
• Figure 4-11: Canada - Forecast for Pharmaceutical Sales (in Billion CA$), 2008-2012
• Figure 4-12: Canada - Forecast for Generic Drug Sales (in Billion CA$), 2008-2012
• Figure 4-13: Canada - Forecast for Branded Drug Sales (in Billion CA$), 2008-2012
• Figure 4-14: Canada - Forecast for Share of Branded & Generic Drugs by Prescription (%), 2008-2012
• Figure 4-15: Canada - Forecast for Branded & Generic Drugs by Sales (%), 2008-2012
• Figure 4-16: Canada - Forecast for Contribution of Branded & Generic Drug Sales in Growth of Pharmaceutical Market (%), 2007 to 2012
• Figure 5-1: Canada - Nominal GDP (in Million US$), 2001-2007E
• Figure 5-2: Canada - Consumer Price Index (%), 2001-2007E
• Figure 5-3: Canada - Forecast for Consumer Price Index (%), 2008-2011
• Figure 5-4: Canada - Currency Exchange Rates (From CA$ to US$), 2001-2007
• Figure 5-5: Canada - Population (in Million), 2001-2007E
• Figure 5-6: Canada - Forecast for Population (in Million), 2008-2011
• Figure 5-7: Canada - Life Expectancy (in Years), 2001-2007E
• Figure 5-8: Canada - Forecast for Life Expectancy (in Years), 2008-2011
• Figure 5-9: Canada - Population Breakup by Age Group (%), 2002-2007E
• Figure 5-10: Canada - Forecast for Population Breakup by Age Group (%), 2008-2011
• Figure 5-11: Canada - Per Head Healthcare Spending (in US$), 2001-2007E
• Figure 5-12: Canada - Forecast for Per Head Healthcare Spending (in US$), 2008-2011
• Figure 5-13: Canada - Number of Doctors (per ‘000 Population), 2002-2007E
• Figure 5-14: Canada - Forecast for Number of Doctors (per ‘000 Population), 2008-2011
• Figure 5-15: Canada - Number of Hospital Beds (per ‘000 Population), 2001-2007E
• Figure 5-16: Canada - Forecast for Number of Hospital Beds (per ‘000 Population), 2008-2011

List of Tables:

• Table 2-1: Canada - Top 10 Therapy Areas by Prescription* (in ‘000), 2006
• Table 2-2: Canada - Top 10 Therapy Areas by Sales* (in ‘000 CA$), 2006
• Table 2-3: Canada - Top Pharmaceutical Companies by Retail Prescription (in Million), 2006
• Table 2-4: Canada - Ranking of Top Pharmaceutical Companies by Retail Prescription (2001-2006)
• Table 2-5: Canada - Top Pharmaceutical Companies by Sales* (in Million CA$), 2006
• Table 2-6: Canada - Ranking of Top Pharmaceutical Companies by Sales* (2001-2006)
• Table 2-7: Canada - Top Drugs in Pharmaceutical Market by Prescription* (in Million), 2006
• Table 2-8: Canada - Top Drugs in Pharmaceutical Market by Sales* (in Million CA$), 2006
• Table 3-1: Canada - Top Generic Drug Companies by Retail Prescription (in Million), 2006
• Table 3-2: Canada - Ranking of Top Generic Drug Companies by Retail Prescription (2002-2006)
• Table 3-3: Canada - Top Generic Drug Companies by Sales* (in Million CA$), 2006
• Table 3-4: Canada - Ranking of Top Generic Drug Companies by Sales* (2002-2006)
• Table 3-5: Canada - Pharmaceutical Sales by Distribution Channel (%), 2002-2006
• Table 3-6: Canada - Generic Drug Market by Retail & Hospital Sales (%), 2007E
• Table 3-7: Canada - Number of Retail Pharmacies by Category (2001-2006)
• Table 3-8: Canada - Top Therapy Areas by Retail Sales (in Million CA$), 2006
• Table 3-9: Canada - Ranking of Top Generic Players by Retail Sales (2006)
• Table 3-10: Canada - Top Therapy Areas by Hospital Sales (in Million CA$), 2006
• Table 3-11: Canada - Ranking of Top Generic Players by Hospital Sales (2006)
• Table 3-12: Canada - Per Capita Drug Spending of Public & Private Sector by Region (in CA$), 2006E
• Table 3-13: Canada - Generic Drug Prescriptions by Region (%), 2001-2006
• Table 3-14: Canada - Generic Drug Sales by Region (%), 2004 & 2006
• Table 4-1: Canada - Returns for Pharmacists on Generic & Branded Drug (in CA$)
• Table 6-1: Mylan Laboratories Inc. - Key Financials (in Million US$), 2005-2007
• Table 6-2: Teva Pharmaceutical Industries Limited - Key Financials (in Million US$), 2004-2006
• Table 6-3: Sandoz Inc. - Key Financials (in Million US$), 2005 & 2006